OncoMed Pharmaceuticals, Inc. To Present At The Jefferies and Co. 2014 Global Healthcare Conference

REDWOOD CITY, Calif., May 28, 2014 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals, Inc. (Nasdaq:OMED), a clinical-stage company developing novel therapeutics that target cancer stem cells (CSCs), or tumor-initiating cells, today announced that Paul J. Hastings, OncoMed's Chairman and Chief Executive Officer, will present an overview of the company at the Jefferies 2014 Global Healthcare Conference being held in New York City.

Help employers find you! Check out all the jobs and post your resume.